Prezista FDA Approval History
FDA Approved: Yes (First approved June 23, 2006)
Brand name: Prezista
Generic name: darunavir
Dosage form: Tablets
Previous Name: TMC114
Company: Janssen Pharmaceuticals, Inc.
Treatment for: HIV Infection
Prezista (darunavir) is a protease inhibitor used with ritonavir in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV) infection.
Development timeline for Prezista
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.